Ertaipenem side chain, Promotion Season Now in Store and Free Sample for Testing with Factory Price
- Chemical Name: Side Train of Ertapenem
- CAS No.: 202467-69-4
- Molecular Fomula: :C20H19N3O7S
- Molecular weight:445.45
- Appearance: Colorless liquid
- Sample:Available
Send Inquiry
Download Quotation

Description of Ertaipenem side chain
3-[[[(2S,4S)-1-(4-Nitrobenzyloxycarbonyl)-4-mercaptopyrrolidin-2-yl]carbonyl]amino]benzoic Acid is an intermediate in the preparation of Ertapenem and intermediates.
Basic Info of Ertaipenem side chain
Basic Info
Numbering system
Properties
Safety Info
Basic Info
| Chemical Name | 3-[[[(2S,4S)-4-Mercapto-1-(4-nitrobenzyloxy)carbonyl-2-pyrrolidinyl]carbonyl]amino]benzoic acid |
| Synonyms | SIDECHAINIFORERTAPENEM;ERTAPENEM SIDE CHAIN 1;Side Chain of ErtapeneM;Ertaipenem side chain;Ertapenem side chain;Expand |
| CAS No. | 202467-69-4 |
| Molecular Formula | C20H19N3O7S |
| Molecular Weight | 445.44600 |
| PSA | 180.56000 |
| LogP | 3.47510 |
Numbering system
| EINECS number | 606-474-0 |
Properties
| Density | 1.5g/cm3 |
| Boiling Point | 749.6ºC at 760 mmHg |
| Flash Point | 407.1ºC |
| Refractive Index | 1.675 |
| Vapor Pressure | 1.33E-23mmHg at 25°C |
Safety Info
| HS Code | 2933990090 |
What is Side Train of Ertapenem?
- With the progress of science and technology and the development of society, chemical products have invariably permeated our daily lives, in medicine, food, cosmetics, electronics, industry, and other areas, becoming an essential part of our lives. One such product is Side Train of Ertapenem which has developed particularly rapidly in recent years. Do you know about Side Train of Ertapenem ?
- The official answer:Carbapenem antibiotics are new β-lactam antibiotics that are stable to β-lactamases. They are classified into 3 types according to the antibacterial spectrum. Type 1: Broad-spectrum carbapenems with limited antibacterial activity against non-fermentative gram-negative bacilli, such as ertapenem, for community-acquired infections. Type 2: Broad-spectrum with antibacterial activity against non-fermentative gram-negative bacilli, such as imipenem and meropenem, for hospital-acquired infections. Type 3: Clinically active against drug-resistant staphylococci, not yet available. Carbapenem antibiotics can be used effectively for moderate to severe infections caused by bacterial multi-drug resistance and are considered an important line of defense against infection in humans. With the increasing severity of bacterial resistance problems, there is a growing interest in carbapenem antibiotics. Among the marketed panel varieties, ertapenem is a very distinctive one with a long plasma half-life due to the benzoic acid structure in its structure, making it a novel broad-spectrum carbapenem antibiotic with novel structure, non-gastrointestinal delivery, long-acting, and stability to DHP-1. Ertapenem sodium (ertapenem), chemically named (1R,5S,6S,8R,2S*,4S*)-2-[2-[3-carboxy-phenylcarbamoyl]-pyrrolidinyl-4-thio]-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid monosodium salt, was developed by Merck and launched in the United States and Europe in November 2001 and April 2002, respectively. It was marketed in the United States and Europe in November 2001 and April 2002 respectively, and then in the United Kingdom, Ireland, Israel, and the Philippines, and in China in 2005. It has good antibacterial activity and pharmacokinetic properties, with a long half-life, and satisfactory results can be obtained with one daily dose. It has been approved for the treatment of complicated abdominal infections, complicated skin tissue infections, complicated urinary tract infections, and gynecological infections in adults, and can be used in young children over 3 months of age, so it has great market potential.
What’s the application of Side Train of Ertapenem?
- It is indicated for the treatment of a wide range of bacterial infections in adults, including intra-abdominal infections, skin and skin tissue infections, urinary tract infections, obstetrical and gynecological infections, and pneumonia. The chemical name of Ertapenem side chain II is 3-[(2S,4S)-4-mercaptopyrrolidine-2-carbamido]benzoic acid hydrochloride. Ertapenem (MK-0826, L-749, trade name Invanztm) is a new broad-spectrum, long-acting 1β-methylcarbapenem antibiotic developed by Merck in the United States and marketed in the United States and Europe in November 2001 and April 2002, respectively. It has good antibacterial activity and pharmacokinetic properties and has significant effects on both Gram-positive and negative aerobic and anaerobic bacteria. Ertapenem side chain II is the deprotective side chain of Ertapenem.
Conclusion
Sincere to the customer and in good faith of quality is our forever followed motto. It’s the basement to be a human and do business. We take all responsibility for our products and service sincerely. We are a company integrating R&D, production, and sales. The design, research, and development of pharmaceutical intermediates including more than 330 kinds of pharmaceutical intermediates such as Anti-infectives, Cardiovascular and Cerebrovascular Systems, Digestive System, Santi-tumor, Nervous System, Geriatric Drugs, and Gynecological Drugs. At the same time, we have more than 4,000 factories in strategic cooperation with nearly 50,000 chemical products, so we can provide you with a one-stop purchasing service, which greatly saves customers’ procurement costs and time.
Keywords of Side Train of Ertapenem
Ertaipenem side chain , 202467-69-4, buy Ertaipenem side chain, Ertaipenem side chain supplier, purchase Ertaipenem side chain, Ertaipenem side chain cost, Ertaipenem side chain manufacturer, order BErtaipenem side chain, high pur Ertaipenem side chain Ertaipenem side chain
